HoneyBear Biosciences

Bead Biopharma

This company develops chemical platform technologies to improve the stability and performance of antibody-drug conjugates for pharmaceutical developers and cancer researchers.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Kivu Bioscience

Kivu Bioscience develops next-generation antibody-drug conjugates to provide oncology treatments for cancer patients while reducing off-target side effects.

Pinot Bio

The company develops antibody-drug conjugate platforms and targeted anticancer therapeutics for pharmaceutical firms and clinical-stage biotechnology partners.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

SynAffix

This company licenses a technology platform for antibody-drug conjugate development to pharmaceutical and biotechnology firms to enable targeted cancer treatments.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

BigHat Biosciences

BigHat Biosciences develops machine learning-designed antibody therapeutics for pharmaceutical partners and patients in oncology and immunology.